These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29082496)

  • 41. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
    Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
    Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus.
    Yadav A; Kumar B; Lang JC; Teknos TN; Kumar P
    Oncogene; 2017 Nov; 36(46):6374-6382. PubMed ID: 28745314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STAT3 Regulation By S-Nitrosylation: Implication In Cancer.
    Singh I; Kim J; Singh AK; Sharma AK; Won JS
    Redox Biol; 2015 Aug; 5():416-417. PubMed ID: 28162277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells.
    Onishi A; Chen Q; Humtsoe JO; Kramer RH
    Exp Cell Res; 2008 Jan; 314(2):377-86. PubMed ID: 17961551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperosmotic stress sustains cytokine-stimulated phosphorylation of STAT3, but slows its nuclear trafficking and impairs STAT3-dependent transcription.
    Ng IH; Jans DA; Bogoyevitch MA
    Cell Signal; 2014 Apr; 26(4):815-24. PubMed ID: 24394455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
    Hahm ER; Singh SV
    Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium orthovanadate suppresses palmitate-induced cardiomyocyte apoptosis by regulation of the JAK2/STAT3 signaling pathway.
    Liu J; Fu H; Chang F; Wang J; Zhang S; Caudle Y; Zhao J; Yin D
    Apoptosis; 2016 May; 21(5):546-57. PubMed ID: 26921179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Signal Inhibition Reveals JAK/STAT3 Pathway as Critical for Bovine Inner Cell Mass Development.
    Meng F; Forrester-Gauntlett B; Turner P; Henderson H; Oback B
    Biol Reprod; 2015 Dec; 93(6):132. PubMed ID: 26510863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
    Rocha J; Zouanat FZ; Zoubeidi A; Hamel L; Benidir T; Scarlata E; Brimo F; Aprikian A; Chevalier S
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):140-9. PubMed ID: 23906537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
    Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
    Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PASD1 promotes STAT3 activity and tumor growth by inhibiting TC45-mediated dephosphorylation of STAT3 in the nucleus.
    Xu ZS; Zhang HX; Zhang YL; Liu TT; Ran Y; Chen LT; Wang YY; Shu HB
    J Mol Cell Biol; 2016 Jun; 8(3):221-31. PubMed ID: 26892021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway.
    Riebe C; Pries R; Schroeder KN; Wollenberg B
    Anticancer Res; 2011 Nov; 31(11):3819-25. PubMed ID: 22110204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
    Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
    Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.